Can any practicing oncologist provide insight into if certain cancer types tend to bring in more money for a practice? Since a lot of breast cancer patients are on maintenance oral medication, I would think they dont tend to bring as much money in as lung and GI patients that may be getting more chemo infusions.
If there are certain cancer types that are more "lucrative" to treat, what's to stop a practice from focusing on acquiring patients with those cancer types? And what is to stop community providers from "specializing" in the more lucratice cancer types within their practice, especially if they get paid a share of what they bring in? I wish it went without saying, but of course this type of practice would be abhorrent. Clearly there are bad players in all groups so if this dynamic exists, I am surprised I have not heard of it happening.
Thanks!
If there are certain cancer types that are more "lucrative" to treat, what's to stop a practice from focusing on acquiring patients with those cancer types? And what is to stop community providers from "specializing" in the more lucratice cancer types within their practice, especially if they get paid a share of what they bring in? I wish it went without saying, but of course this type of practice would be abhorrent. Clearly there are bad players in all groups so if this dynamic exists, I am surprised I have not heard of it happening.
Thanks!
Last edited: